NCT04224246View on ClinicalTrials.gov

Impact of Gamma-OH on Sleep in ICU Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 27, 2020

Primary Completion Date

February 9, 2023

Study Completion Date

February 9, 2023

Conditions
Weaning from Mechanical Ventilation
Interventions
DRUG

Gamma Hydroxybutyrate

Gamma-OH® will be administered intravenously at a dose of 20 mg/kg/h for 6 hours

Trial Locations (1)

86000

CHU Poitiers, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT04224246 - Impact of Gamma-OH on Sleep in ICU Patients | Biotech Hunter | Biotech Hunter